Compare Neoadjuvant Chemotherapy of DOS Versus SOX in Locally Advanced Gastric Adenocarcinoma.

NCT03691454 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

258

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma

Interventions

DRUG: Docetaxel
DRUG: Oxaliplatin

Sponsor

Peking University